GUJALKALI

Gujarat Alkalies and Chemicals Balance Sheet

₹612.60-0.08%
Market cap
₹4,499 crore
P/E
67.8
P/B
0.87
ROE
-0.0%
Dividend yield
2.89%

As of Mar 2022, Gujarat Alkalies and Chemicals had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 101.16% from Mar 2023.

Gujarat Alkalies and Chemicals balance sheet

As at each financial year end, newest first. H1 = half-year.

Gujarat Alkalies and Chemicals balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital50073.4473.4473.4473.44
Reserves8,5002,2371,8251,6561,517
Borrowings1,200597544779809
Other liabilities3,5001,5991,4041,5391,533
Total liabilities13,7008,3358,0237,9877,533
Fixed assets6,5004,8844,7344,6804,524
Capital work in progress400100100100100
Investments2,5001,6671,6051,5971,507
Other assets4,3002,5002,4072,3962,260
Total assets13,7008,3358,0237,9877,533

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Gujarat Alkalies and Chemicals balance sheet — frequently asked questions

What is the total debt of Gujarat Alkalies and Chemicals?

Gujarat Alkalies and Chemicals reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹597 crore as of Mar 2023.

What is Gujarat Alkalies and Chemicals' debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Gujarat Alkalies and Chemicals' debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Gujarat Alkalies and Chemicals' total assets?

Gujarat Alkalies and Chemicals' total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Gujarat Alkalies and Chemicals With ATS

Track GUJALKALI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.